Tieton Capital Management LLC reduced its position in shares of Chromadex Corp (OTCMKTS:CDXC) by 10.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 616,620 shares of the company’s stock after selling 72,115 shares during the period. Chromadex Corp accounts for about 2.2% of Tieton Capital Management LLC’s portfolio, making the stock its 21st largest holding. Tieton Capital Management LLC owned 1.55% of Chromadex Corp worth $2,355,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CDXC. North Star Investment Management Corp. grew its position in shares of Chromadex Corp by 78.9% in the second quarter. North Star Investment Management Corp. now owns 265,334 shares of the company’s stock valued at $1,014,000 after purchasing an additional 117,000 shares in the last quarter. LMR Partners LLP purchased a new stake in shares of Chromadex Corp in the second quarter valued at approximately $347,000. Bank of Montreal Can purchased a new stake in shares of Chromadex Corp in the second quarter valued at approximately $168,000. Finally, Segall Bryant & Hamill LLC grew its position in shares of Chromadex Corp by 0.3% in the first quarter. Segall Bryant & Hamill LLC now owns 38,834 shares of the company’s stock valued at $104,000 after purchasing an additional 133 shares in the last quarter.

A number of equities research analysts have recently issued reports on CDXC shares. HC Wainwright set a $5.00 price target on Chromadex Corp and gave the company a “buy” rating in a research report on Friday, August 11th. ValuEngine upgraded Chromadex Corp from a “sell” rating to a “hold” rating in a report on Tuesday, June 20th. Finally, Zacks Investment Research cut Chromadex Corp from a “hold” rating to a “sell” rating in a report on Monday, July 17th.

Chromadex Corp (OTCMKTS CDXC) traded up 16.51% on Thursday, reaching $3.74. The company had a trading volume of 1,104,292 shares. The stock’s market capitalization is $172.39 million. The stock has a 50 day moving average price of $3.31 and a 200 day moving average price of $3.15. Chromadex Corp has a 52-week low of $2.25 and a 52-week high of $4.19.

Chromadex Corp (OTCMKTS:CDXC) last posted its earnings results on Thursday, August 10th. The company reported ($0.05) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.04 by $0.09. The business had revenue of $5.31 million for the quarter, compared to analyst estimates of $11 million. Chromadex Corp had a negative net margin of 52.09% and a negative return on equity of 63.19%. Analysts expect that Chromadex Corp will post ($0.14) EPS for the current year.

In other news, insider Robert N. Fried bought 10,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was purchased at an average price of $3.15 per share, for a total transaction of $31,500.00. Following the transaction, the insider now owns 583,241 shares in the company, valued at $1,837,209.15. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Step Holdings Ltd Pioneer bought 786,167 shares of the firm’s stock in a transaction on Friday, August 18th. The stock was purchased at an average price of $2.60 per share, with a total value of $2,044,034.20. The disclosure for this purchase can be found here. Insiders acquired a total of 798,167 shares of company stock worth $2,082,154 in the last quarter.

COPYRIGHT VIOLATION NOTICE: “Tieton Capital Management LLC Cuts Holdings in Chromadex Corp (CDXC)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/07/tieton-capital-management-llc-cuts-holdings-in-chromadex-corp-cdxc.html.

About Chromadex Corp

Chromadex Corporation and its subsidiaries ChromaDex, Inc, ChromaDex Analytics, Inc and Spherix Consulting, Inc provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets.

Want to see what other hedge funds are holding CDXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chromadex Corp (OTCMKTS:CDXC).

Institutional Ownership by Quarter for Chromadex Corp (OTCMKTS:CDXC)

Receive News & Stock Ratings for Chromadex Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chromadex Corp and related stocks with our FREE daily email newsletter.